close

Enter

Log in using OpenID

Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Favourable regulatory guidelines for designing and manufacturing of IVT injectables in the interest of patient safety is the primary driving factor for market growth.
Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2029
Favourable regulatory guidelines for designing and manufacturing of IVT injectables
in the interest of patient safety is the primary driving factor for market growth.
However, injectables are also associated with multiple risks or complications like
inflammation and infection in the eye, vitreous haemorrhage and retinal detachment
are expected to restrain the market growth.
The global intravitreal (IVT) injectables market is poised to value over USD 5 billion by
2029 end.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=259&page=requestsample
Insights on Global Intravitreal Injectables Market:
1. By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
IVT injection is the most common eye treatment procedure in the U.S, this region
dominates the global market. Furthermore, an increase in the geriatric population in
not only North American but also in the European region is further fuelling the
market growth in both the regions.
India and China comprise of numerous patients suffering from diabetes mellitus
which can also result in diabetic retinopathy which increases the demand for IVT
injectables thus accelerating the market growth in the Asia Pacific region.
2. By Drug Class
• Anti-VEGF
• Antibiotics
• Corticosteroids
• Antifungals
• Antivirals
The anti-VEGF segment dominates the global market. The characteristics of antiVEGF drugs are crucial with respect to the treatment of ocular diseases its ability to
minimize fluid leakage that occurs while treating such diseases. Additionally, these
drugs are capable of binding growth factors and in suppressing the formation of
irregular RBCs in ocular diseases. Aforementioned, are the factors that drive this
market segment resulting in its substantial growth.
3. By Indication
• Diabetic Retinopathy
• Macular Degeneration
• Endophthalmitis
• Retinal Vein Occlusions
Macular degeneration, age-related macular degeneration, in particular, is primarily
observed in the North American region which is a huge market scope and therefore
the macular degeneration market segment dominates this market segment and this
trend will continue during the forecast period considering the constant rise in the
geriatric population.
4. By Distribution
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Mail order Pharmacies
Hospital pharmacies dominate the global market due to the amount of medical stock
that these pharmacies possess. Additionally, the integration with hospitals makes it
easy for the patients to access these medicines which are generally expensive in drug
stores not associate with them and hence this market segment will continue to
dominate the global market during the forecast period.
Competitive Landscape:
• Bausch & Lomb
• Novartis AG
• Allergan
• F. Hoffmann-La Roche Ltd.
• Thrombogenics Inc.
• Alimera Sciences
Allergan’s Ozurdex intravitreal implant is used for treating diabetic macular edema
(DME) by injecting corticosteroids at regular intervals once it is implanted in the eye.
The implantation process of Ozurdex is not time-consuming and the implant gets
dissolve naturally without requiring any surgical procedures for its removal. These
advantages of Ozurdex will help Allergan establish its market position.
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=259&license=single
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global wrinkle fillers market on the
basis of filler type, end-user, and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in five key regions (along with countries)—North
America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches,
technological
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
3
File Size
15 KB
Tags
healthcare, market, health
1/--pages
Report inappropriate content